 Creative Planning acquired a new position in shares of Agios Pharmaceuticals Inc NASDAQ:AGIO in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 4,785 shares of the biopharmaceutical companys stock, valued at approximately 256,000. Other hedge funds have also made changes to their positions ... 